Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Nov 15;327(7424):1141-2.
doi: 10.1136/bmj.327.7424.1141.

Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study

Morten Svensson  1 , Finn Gustafsson, Søren Galatius, Per R Hildebrandt, Dan Atar
Affiliations

Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study

Morten Svensson et al. BMJ. .
No abstract available

PubMed Disclaimer

References

    1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341: 709-17. (Randomized Aldactone Evaluation Study Investigators.) - PubMed
    1. Greenberg B. Treatment of heart failure: state of the art and prospectives. J Cardiovasc Pharmacol 2002;38: 59-63. - PubMed
    1. Remme WJ, Swedberg K. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Eur J Heart Fail 2002;4: 11-22. (Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology.) - PubMed
    1. Galatius S, Gustafsson F, Nielsen PN, Atar D, Hildebrandt PR. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J 2002;144(suppl): S2. - PubMed
    1. Pitt B, Remme W, Zannad F, Neaton J, Gatlin M, Roniker B, et al. A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction. N Engl J Med 2003;348: 1309-21. (Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.) - PubMed

Publication types